Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (5) | B (2) | C (4) | D (4) | E (8) | F (1) | G (4) | I (3) | L (3) | N (1) | O (2) | P (2) | R (1) | S (6) | T (7) | U (1) | V (1) | W (2)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
Abemaciclib Verzenio Protein kinase inhibitor 2019/07/03
Alpelisib Piqray Antineoplastic agent 2020/03/11
Apalutamide Erleada Anti-androgen 2018/07/27
Apomorphine Kynmobi Nonergot-derivative dopamine receptor agonist 2020/06/12
Axicabtagene ciloleucel Yescarta Antineoplastic agent 2019/11/27
Baloxavir marboxil Xofluza Antiviral agent 2020/02/19
Brolucizumab Beovu Antineovascularisation agent 2020/05/15
Cabotegravir Vocabria Antiretroviral agent 2020/03/19
Cabotegravir + rilpivirine Cabenuva Antiretroviral agent 2020/03/19
Caplacizumab Cablivi Antithrombotic agent 2020/09/04
Cemiplimab Libtayo Antineoplastic agent 2019/05/24
Dacomitinib Vizimpro Tyrosine kinase inhibitor 2019/04/22
Daratumumab Darzalex SC Antineoplastic agent, monoclonal antibody 2020/08/12
Darolutamide Nubeqa Anti-androgen 2020/03/24
Drospirenone + estetrol Nextstellis Oral contraceptive 2021/06/15
Edaravone Radicava Treatment for amyotrophic lateral sclerosis 2019/10/29
Elexacaftor + tezacaftor + ivacaftor Trikafta Cystic fibrosis transmembrane conductance regulator correctors 2021/06/22
Entrectinib Rozlytrek Antineoplastic agent
Eptinezumab Vyepti Prevention of migraine; calcitonin gene-related peptide binding antibody 2021/01/11
Erdafitinib Balversa Protein kinase inhibitor 2019/12/09
Esketamine Spravato Antidepressant 2020/05/20
Eszopiclone Lunesta Hypnotic 2020/10/20
Etonogestrel Nexplanon Hormonal contraceptive 2020/08/17
Fremanezumab Ajovy Anti-calcitonin gene-related peptide 2020/08/04
Galcanezumab Emgality CGRP binding antibody 2019/10/02
Gilteritinib Xospata Antineoplastic agent 2020/02/03
Glasdegib Daurismo Antineoplastic agent 2020/08/10
Glucagon Baqsimi Hyperglycemic agent 2019/11/20
Indacaterol + glycopyrronium bromide + mometasone Enerzair Breezhaler Asthma medication 2020/11/05
Infliximab Avsola Biological response modifier 2020/06/01
Isatuximab Sarclisa Antineoplastic agent, monoclonal antibody 2020/07/03
Larotrectinib Vitrakvi Antineoplastic agent 2019/07/10
Lemborexant Dayvigo Hypnotic 2020/11/06
Lorlatinib Lorbrena Tyrosine kinase inhibitor 2019/04/22
Niraparib Zejula Antineoplastic agent 2020/01/09
Ofatumumab Kesimpta Immunomudulator 2021/04/08
Syndicate content